[HTML][HTML] Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment

AC Bibby, S Tsim, N Kanellakis, H Ball… - European …, 2016 - Eur Respiratory Soc
Malignant pleural mesothelioma is an aggressive malignancy of the pleural surface,
predominantly caused by prior asbestos exposure. There is a global epidemic of malignant pleural …

[HTML][HTML] British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma

…, T Peel, NM Rahman, M Slade, J Steele, S Tsim… - Thorax, 2018 - thorax.bmj.com
Refer all patients with a chest X-ray suggestive of MPM urgently (via the 2-week wait
suspected cancer pathway in England and Wales). Consider referral for further investigation in …

Survival prediction in mesothelioma using a scalable Lasso regression model: instructions for use and initial performance using clinical predictors

AC Kidd, M McGettrick, S Tsim… - BMJ open …, 2018 - bmjopenrespres.bmj.com
Introduction Accurate prognostication is difficult in malignant pleural mesothelioma (MPM).
We developed a set of robust computational models to quantify the prognostic value of …

Imaging in pleural mesothelioma: A review of the 13th International Conference of the International Mesothelioma Interest Group

SG Armato III, KG Blyth, JJ Keating, S Katz, S Tsim… - Lung cancer, 2016 - Elsevier
Imaging plays an important role in the detection, diagnosis, staging, response assessment,
and surveillance of malignant pleural mesothelioma. The etiology, biology, and growth …

[HTML][HTML] The diagnostic performance of routinely acquired and reported computed tomography imaging in patients presenting with suspected pleural malignancy

S Tsim, DB Stobo, L Alexander, C Kelly, KG Blyth - Lung Cancer, 2017 - Elsevier
Objectives Contrast-enhanced computed tomography (CT) provides essential cross-sectional
imaging data in patients with suspected pleural malignancy (PM). The performance of CT …

BTS guideline for the investigation and management of malignant pleural mesothelioma

…, M Slade, J Steele, S Tsim… - BMJ open …, 2018 - bmjopenrespres.bmj.com
The full guideline for the investigation and management of malignant pleural mesothelioma
is published in Thorax. The following is a summary of the recommendations and good …

Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational study

S Tsim, C Kelly, L Alexander, C McCormick… - BMJ open, 2016 - bmjopen.bmj.com
Introduction Malignant pleural mesothelioma (MPM) is an asbestos-related cancer, which is
difficult to diagnose. Thoracoscopy is frequently required but is not widely available. An …

[HTML][HTML] Early contrast enhancement: a novel magnetic resonance imaging biomarker of pleural malignancy

S Tsim, CA Humphreys, GW Cowell, DB Stobo… - Lung Cancer, 2018 - Elsevier
Introduction Pleural Malignancy (PM) is often occult on subjective radiological assessment.
We sought to define a novel, semi-objective Magnetic Resonance Imaging (MRI) biomarker …

Inter‐observer variation in image interpretation and the prognostic importance of non‐expansile lung in malignant pleural effusion

GA Martin, AC Kidd, S Tsim, P Halford, A Bibby… - …, 2020 - Wiley Online Library
Background and objective Non‐expansile lung (NEL) frequently complicates management
of malignant pleural effusion (MPE) and is an important factor in clinical practice and trials. …

Fully automated volumetric measurement of malignant pleural mesothelioma by deep learning AI: Validation and comparison with modified RECIST response criteria

…, GW Cowell, AJ Weir, JP Voisey, M Evison, S Tsim… - Thorax, 2022 - thorax.bmj.com
Background In malignant pleural mesothelioma (MPM), complex tumour morphology results
in inconsistent radiological response assessment. Promising volumetric methods require …